Eli Lilly and Company
LLYNYSE
$1,294.35
Last price · USD
- Market cap
- $1.16T
- P/E
- 56.4x
- EV / EBITDA
- 37.8x
- P/S
- 17.8x
- FCF yield
- 0.8%
- Div. yield
- 0.46%
Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.
Eli Lilly and Company key metrics & ratios
Annual · USD millions except per-share data · 36 lines
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | CAGR | |
|---|---|---|---|---|---|---|---|
| Growth (year over year) | |||||||
| Revenue growth | 44.7% | 32.0% | 19.6% | 0.8% | — | — | |
| Operating income growth | 74.3% | 58.0% | 24.7% | 9.1% | — | — | |
| Net income growth | 94.9% | 102.1% | -16.1% | 11.9% | — | — | |
| EPS (diluted) growth | 96.0% | 101.9% | -11.7% | 12.3% | — | — | |
| Free cash flow growth | 138.6% | 219.3% | -168.5% | -14.6% | — | — | |
| Margins | |||||||
| Gross margin | 83.0% | 81.3% | 79.2% | 76.8% | 74.2% | — | |
| Operating margin | 45.6% | 37.8% | 31.6% | 30.3% | 28.0% | — | |
| EBITDA margin | 48.6% | 41.8% | 25.1% | 30.3% | 28.4% | — | |
| Net margin | 31.7% | 23.5% | 15.4% | 21.9% | 19.7% | — | |
| FCF margin | 13.8% | 8.3% | -9.2% | 16.1% | 19.0% | — | |
| Returns on capital | |||||||
| Return on equity | 77.8% | 74.6% | 48.6% | 58.6% | 62.2% | — | |
| Return on assets | 18.4% | 13.5% | 8.2% | 12.6% | 11.4% | — | |
| Return on invested capital | 38.5% | 31.9% | 26.0% | 32.0% | 32.6% | — | |
| Leverage & liquidity | |||||||
| Debt / equity | 1.60x | 2.37x | 2.34x | 1.52x | 1.88x | — | |
| Net debt / EBITDA | 1.12x | 1.62x | 2.62x | 1.64x | 1.62x | — | |
| Current ratio | 1.58x | 1.15x | 0.94x | 1.05x | 1.23x | — | |
| Interest coverage | 37.34x | 21.83x | 22.20x | 26.10x | 23.35x | — | |
| Profitability & operating | |||||||
| EBIT | 29,696 | 17,040 | 7,041 | 7,138 | 6,495 | +46.2% | |
| EBITDA | 31,693 | 18,807 | 8,568 | 8,661 | 8,043 | +40.9% | |
| Operating income | 29,696 | 17,040 | 10,787 | 8,653 | 7,933 | +39.1% | |
| Income before tax | 25,731 | 12,680 | 6,555 | 6,806 | 6,156 | +43.0% | |
| Net income | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 | +38.7% | |
| Earnings per share | |||||||
| EPS (basic) | $23.07 | $11.76 | $5.83 | $6.57 | $5.85 | +40.9% | |
| EPS (diluted) | $22.95 | $11.71 | $5.80 | $6.57 | $5.85 | +40.7% | |
| Share count (millions) | |||||||
| Weighted avg shares outstanding | 898 | 901 | 899 | 950 | 954 | -1.5% | |
| Weighted avg shares outstanding (diluted) | 898 | 904 | 903 | 950 | 954 | -1.5% | |
| Balance sheet highlights | |||||||
| Net debt | 35,340 | 30,376 | 22,407 | 14,172 | 13,066 | +28.2% | |
| Total debt | 42,503 | 33,644 | 25,225 | 16,239 | 16,885 | +26.0% | |
| Total investments | 2,907 | 3,371 | 3,161 | 3,047 | 3,303 | -3.1% | |
| Total stockholders' equity | 26,535 | 14,192 | 10,772 | 10,650 | 8,979 | +31.1% | |
| Total assets | 112,476 | 78,715 | 64,006 | 49,490 | 48,806 | +23.2% | |
| Cash flow highlights | |||||||
| Free cash flow | 8,972 | 3,760 | (3,152) | 4,600 | 5,388 | +13.6% | |
| Operating cash flow | 16,813 | 8,818 | 4,240 | 7,586 | 7,366 | +22.9% | |
| Capital expenditure | (7,841) | (5,058) | (7,392) | (2,985) | (1,978) | — | |
| Net cash from operating activities | 16,813 | 8,818 | 4,240 | 7,586 | 7,366 | +22.9% | |
| Additional fields | |||||||
| Accrued Expenses | 0 | 11,539 | 11,689 | 8,784 | 1,034 | — | |